The treatment of Alzheimer's Disease & Weight Loss with vitamins

Alzheimer's Disease and Weight Loss: Mitamins custom make quality formulas for the treatment of Alzheimer's Disease & Weight Loss with vitamins. A Alzheimer's Disease & Weight Loss formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Alzheimer's Disease and Weight Loss

  • Amount Per Serving
    % DV
    Vitamin C
    200
    mg
    333%
    Vitamin E
    200
    IU
    667%
    Thiamin
    50
    mg
    3333%
    Vitamin B12
    125
    mcg
    2083%
    Flax Seed Powder
    50
    mg
    *
    Ginkgo Extract
    40
    mg
    *
    Green Tea Extract
    50
    mg
    *
    Acetyl L-Carnitine
    250
    mg
    *
  • Amount Per Serving
    % DV
    L-Carnitine
    50
    mg
    *
    L-Glutamine
    50
    mg
    *
    Phosphatidylserine
    100
    mg
    *
    Conjugated Linoleic Acid
    50
    mg
    *
    Pyruvate
    50
    mg
    *
    Cayenne Extract
    50
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Alzheimer's Disease and Weight Loss
Monthly Cost: $46.61
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Alzheimer's Disease and Weight Loss Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Drug Industry Seeks Tests to Spot Side Effect Risks (HealthDay)
Seven major pharmaceutical companies are banding together to develop genetic tests that predict which patients will have adverse side effects from drugs.
FDA Accepts Sucampo's SNDA For Lubiprostone (8 Mcg) For The Treatment Of Irritable Bowel Syndrome With Constipation (IBS-C)
Sucampo Pharmaceuticals, Inc., (Nasdaq: SCMP) announced that the supplemental New Drug Application (sNDA) for lubiprostone (8 mcg, oral gel capsules, twice daily) for the treatment of irritable bowel syndrome with constipation (IBS-C) has been accepted for review by the U.S. Food and Drug Administration (FDA). Sucampo Pharmaceuticals currently anticipates a decision from the FDA in the second quarter of 2008.
This information concerning the support of Alzheimer's Disease and Weight Loss treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Alzheimer's Disease, Brian & Memory Support  Alzheimer's Disease  Alzheimer's Disease and Weight Loss
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments